Literature DB >> 20017191

C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells.

Donald J Weaver1, Edimara S Reis, Manoj K Pandey, Gabriele Köhl, Nathaniel Harris, Craig Gerard, Jörg Köhl.   

Abstract

C5a is a proinflammatory mediator that has recently been shown to regulate adaptive immune responses. Here we demonstrate that C5a receptor (C5aR) signaling in DC affects the development of Treg and Th17 cells. Genetic ablation or pharmacological targeting of the C5aR in spleen-derived DC results in increased production of TGF-beta leading to de novo differentiation of Foxp3(+) Treg within 12 h after co-incubation with CD4(+) T cells from DO11.10/RAG2(-/-) mice. Stimulation of C5aR(-/-) DC with OVA and TLR2 ligand Pam(3)CSK(4) increased TGF-beta production and induced high levels of IL-6 and IL-23 but only minor amounts of IL-12 leading to differentiation of Th cells producing IL-17A and IL-21. Th17 differentiation was also found in vivo after adoptive transfer of CD4(+) Th cell into C5aR(-/-) mice immunized with OVA and Pam(3)CSK(4). The altered cytokine production of C5aR(-/-) DC was associated with low steady state MHC class II expression and an impaired ability to upregulate CD86 and CD40 in response to TLR2. Our data suggest critical roles for C5aR in Treg and Th17-cell differentiation through regulation of DC function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20017191      PMCID: PMC3040298          DOI: 10.1002/eji.200939333

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  39 in total

1.  Toll-like receptors control activation of adaptive immune responses.

Authors:  M Schnare; G M Barton; A C Holt; K Takeda; S Akira; R Medzhitov
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

2.  Mechanism of action of the group A streptococcal C5a inactivator.

Authors:  D E Wexler; D E Chenoweth; P P Cleary
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

Review 3.  Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement.

Authors:  M K Pangburn
Journal:  Immunopharmacology       Date:  2000-08

4.  Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo.

Authors:  K M Murphy; A B Heimberger; D Y Loh
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

5.  The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74).

Authors:  Stuart A Cain; Peter N Monk
Journal:  J Biol Chem       Date:  2001-12-31       Impact factor: 5.157

6.  C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism.

Authors:  Magnus Otto; Heiko Hawlisch; Peter N Monk; Melanie Müller; Andreas Klos; Christopher L Karp; Jörg Köhl
Journal:  J Biol Chem       Date:  2003-10-21       Impact factor: 5.157

7.  C5L2, a nonsignaling C5A binding protein.

Authors:  Shoji Okinaga; Dubhfeasa Slattery; Alison Humbles; Zsusanna Zsengeller; Olivier Morteau; Michele Bennett Kinrade; Robbin M Brodbeck; James E Krause; Hye-Ryun Choe; Norma P Gerard; Craig Gerard
Journal:  Biochemistry       Date:  2003-08-12       Impact factor: 3.162

8.  Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype.

Authors:  Claudia Kemper; Andrew C Chan; Jonathan M Green; Kelly A Brett; Kenneth M Murphy; John P Atkinson
Journal:  Nature       Date:  2003-01-23       Impact factor: 49.962

9.  GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells.

Authors:  Dat Q Tran; John Andersson; Rui Wang; Heather Ramsey; Derya Unutmaz; Ethan M Shevach
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-27       Impact factor: 11.205

10.  Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.

Authors:  Carla J C de Haas; Karin Ellen Veldkamp; Andreas Peschel; Floor Weerkamp; Willem J B Van Wamel; Erik C J M Heezius; Miriam J J G Poppelier; Kok P M Van Kessel; Jos A G van Strijp
Journal:  J Exp Med       Date:  2004-03-01       Impact factor: 14.307

View more
  55 in total

1.  Evidence for anti-inflammatory effects of C5a on the innate IL-17A/IL-23 axis.

Authors:  Markus Bosmann; J Vidya Sarma; Gelareh Atefi; Firas S Zetoune; Peter A Ward
Journal:  FASEB J       Date:  2011-12-27       Impact factor: 5.191

Review 2.  Complement: a key system for immune surveillance and homeostasis.

Authors:  Daniel Ricklin; George Hajishengallis; Kun Yang; John D Lambris
Journal:  Nat Immunol       Date:  2010-08-19       Impact factor: 25.606

Review 3.  Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.

Authors:  M A Khan; J L Hsu; A M Assiri; D C Broering
Journal:  Clin Exp Immunol       Date:  2015-11-05       Impact factor: 4.330

4.  Complement regulates conventional DC-mediated NK-cell activation by inducing TGF-β1 in Gr-1+ myeloid cells.

Authors:  Xiaoping Qing; Gloria C Koo; Jane E Salmon
Journal:  Eur J Immunol       Date:  2012-06-05       Impact factor: 5.532

5.  A complement a day keeps the Fox(p3) away.

Authors:  Gaelle Le Friec; Jörg Köhl; Claudia Kemper
Journal:  Nat Immunol       Date:  2013-02       Impact factor: 25.606

Review 6.  Complement and periodontitis.

Authors:  George Hajishengallis
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

Review 7.  Complement in monoclonal antibody therapy of cancer.

Authors:  Laura M Rogers; Suresh Veeramani; George J Weiner
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

8.  Emerging role of C5a/C5aR IL-17A axis in cGVHD.

Authors:  Xiaomei Chen; Peilong Lai; Yulian Wang; Chang He; Suijing Wu; Xin Huang; Suxia Geng; Chengwei Luo; Wei Ling; Lingji Zeng; Peng Li; Zhiwu Jiang; Jianyu Weng; Xin Du
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

Review 9.  The dual role of complement in cancer and its implication in anti-tumor therapy.

Authors:  Ioannis Kourtzelis; Stavros Rafail
Journal:  Ann Transl Med       Date:  2016-07

10.  Complement drives Th17 cell differentiation and triggers autoimmune arthritis.

Authors:  Motomu Hashimoto; Keiji Hirota; Hiroyuki Yoshitomi; Shinji Maeda; Shin Teradaira; Shuji Akizuki; Paz Prieto-Martin; Takashi Nomura; Noriko Sakaguchi; Jörg Köhl; Birgitta Heyman; Minoru Takahashi; Teizo Fujita; Tsuneyo Mimori; Shimon Sakaguchi
Journal:  J Exp Med       Date:  2010-05-10       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.